SCHEMBL19686063

SCHEMBL19686063

Cc1cc(=O)c2cc(N3c4ccccc4[Si]4(c5ccccc5-c5ccccc54)c4ccccc43)ccc2o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.43
CYP1A2 P05177 3/20 0.37
CYP1A1 P04798 2/20 0.37
CYP1B1 Q16678 2/20 0.37
KDM4E B2RXH2 4/20 0.35
POLB P06746 2/20 0.35
ALDH1A1 P00352 3/20 0.34
CYP3A4 P08684 3/20 0.34
HPGD P15428 3/20 0.34
TP53 P04637 3/20 0.34
MAPT P10636 3/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
AR P10275 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CHRNA7 P36544 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19685904 0.91 ACHE (0.36) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL19686066 0.88 ACHE (0.46) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL19685974 0.81 ACHE (0.53) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL19685898 0.79 ACHE (0.38) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL19686064 0.79 ACHE (0.43) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL19686253 0.78 MEN1 (0.35) KDM4EALDH1A1HPGDHSD17B10TSHR
SCHEMBL19686060 0.74 MEN1 (0.35) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL19686107 0.74 MEN1 (0.35) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL19686065 0.74 ACHE (0.46) ACHECYP1A2CYP1A1CYP1B1KDM4E
SCHEMBL19685954 0.74 ACHE (0.43) ACHECYP1A2CYP1A1CYP1B1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-07-14 US disclosed
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10714693-B2 Polycyclic compound and organic electroluminescence device including the same CYC1, CCNA1, CYCS ACHE 3408/4885CYP1A2 902/4885CYP1A1 102/4885
US-20170352817-A1 POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME CYC1, CCNA1, CYCS ACHE 3408/4885CYP1A2 902/4885CYP1A1 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.